STIL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.896000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.339800E-01
Normal-vs-Stage2
2.240800E-01
Normal-vs-Stage3
6.713800E-01
Normal-vs-Stage4
2.942200E-01
Stage1-vs-Stage2
6.208000E-01
Stage1-vs-Stage3
3.605400E-01
Stage1-vs-Stage4
6.771000E-01
Stage2-vs-Stage3
8.832300E-02
Stage2-vs-Stage4
7.905400E-01
Stage3-vs-Stage4
1.739210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.945200E-01
Normal-vs-AfricanAmerican
5.131000E-01
Normal-vs-Asian
2.013000E-01
Caucasian-vs-AfricanAmerican
7.717600E-01
Caucasian-vs-Asian
5.106400E-01
AfricanAmerican-vs-Asian
5.524200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.092000E-01
Normal-vs-Female
2.738800E-01
Male-vs-Female
4.941600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.772200E-01
Normal-vs-Age(41-60Yrs)
1.859800E-01
Normal-vs-Age(61-80Yrs)
3.273800E-01
Normal-vs-Age(81-100Yrs)
5.002400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.948420E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.401800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.167600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.888300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.129000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.781000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.637200E-01
Normal-vs-Daily Drinker
4.080400E-01
Normal-vs-Weekly Drinker
4.262800E-01
Normal-vs-Occasional Drinker
2.368200E-01
Normal-vs-Social Drinker
1.765160E-01
Non Drinker-vs-Daily Drinker
7.935200E-01
Non Drinker-vs-Weekly Drinker
8.027600E-01
Non Drinker-vs-Occasional Drinker
7.458600E-01
Non Drinker-vs-Social Drinker
7.990000E-01
Daily Drinker-vs-Weekly Drinker
9.807800E-01
Daily Drinker-vs-Occasional Drinker
5.707600E-01
Daily Drinker-vs-Social Drinker
6.133400E-01
Weekly Drinker-vs-Occasional Drinker
5.946400E-01
Weekly Drinker-vs-Social Drinker
6.231800E-01
Occasional Drinker-vs-Social Drinker
9.482800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.099400E-01
Normal-vs-Grade 2
9.454600E-01
Normal-vs-Grade 3
9.834000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.58109999999212E-05
Grade 1-vs-Grade 3
1.83221999999761E-05
Grade 1-vs-Grade 4
7.099400E-01
Grade 2-vs-Grade 3
5.282000E-01
Grade 2-vs-Grade 4
9.454600E-01
Grade 3-vs-Grade 4
9.834000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.605600E-01
Normal-vs-NonDiabetic
2.631600E-01
Diabetic-vs-NonDiabetic
1.001210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.157410E-01
Normal-vs-NoPancreatitis
3.554400E-01
Pancreatitis-vs-NoPancreatitis
1.117770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.566800E-01
Normal-vs-N1
2.380000E-01
N0-vs-N1
3.189000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.789900E-02
Normal-vs-TP53-NonMutant
3.249600E-01
TP53-Mutant-vs-TP53-NonMutant
2.26129999999491E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
